Century Therapeutics News and Activities

Century Therapeutics is a company listed under the stock ticker IPSC (US).

View the org chart displaying its 18 main executives

Most searched biographies at Century Therapeutics

• Brent Pfeiffenberger, Chief Executive Officer and Chairman of the ...
• Timothy Walbert, Director
• Alessandro Riva, Independent Director

Popular executive movements at Century Therapeutics

• Bruno Marques, Vice President, Process and Product Development, has left the company  (posted on March 10 2026).
• Martin Murphy has joined the company as Director  (posted on December 9 2025).
• Han Lee has joined the company as Director  (posted on December 9 2025).

Create your alert
to follow the executive moves at Century Therapeutics.

Century Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Century Therapeutics

Social media about Century Therapeutics

• Century Therapeutics on Wikipedia, Google News & Yahoo Finance
• Century Therapeutics on LinkedIn, X (Twitter) & YouTube